AstraZeneca breast cancer drug trial fails to extend lives of patients

It said the drug did not 'achieve statistical significance' in terms of the survival rates of those suffering from breast cancer compared to chemotherapy.

  Economy   Sep 23, 2024   0   47  Add to Reading List
AstraZeneca breast cancer drug trial fails to extend lives of patients






It said the drug did not 'achieve statistical significance' in terms of the survival rates of those suffering from breast cancer compared to chemotherapy.
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow